Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANT-1207 in Primary Axillary Hyperhidrosis
NCT02479139Phase 2Completed
- Sponsor
- Allergan
- Start
- Jun 2015
- Primary completion
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of onabotulinumtoxinA in primary axillary hyperhidrosis (PAH), sponsored by Allergan. Started Jun 2015; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
primary axillary hyperhidrosis (PAH)
Beyond the preview
Go deeper on NCT02479139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02479139.